CD4 and Kaposi's sarcoma: In the HIV-related KS subgroup (7.3%), the younger median age (39.5 years) and higher rates of visceral involvement (50%) reflect patterns documented in the literature, although the absence of CD4 counts and antiretroviral therapy (ART) data limited deeper prognostic insights [10,14,15,19,20].